# Open-Label Single-Arm Pilot Study in Adult Allogeneic Hematopoietic Stem Cell Transplant Recipients With Transfusional Iron Overload

> **NCT01335035** · PHASE4 · COMPLETED · sponsor: **Novartis Pharmaceuticals** · enrollment: 30 (actual)

## Conditions studied

- Iron Overload

## Interventions

- **DRUG:** deferasirox

## Key facts

- **NCT ID:** NCT01335035
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-12
- **Primary completion:** 2011-05
- **Final completion:** —
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2012-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01335035

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01335035, "Open-Label Single-Arm Pilot Study in Adult Allogeneic Hematopoietic Stem Cell Transplant Recipients With Transfusional Iron Overload". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01335035. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*